Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMS Electrochemotherapy for Glioblastoma Multiforme
2015-000608-24Phase 2Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Feb 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of temozolomide in glioblastoma (GBM), sponsored by Aarhus University Hospital. Started Feb 2015; status: terminated.
02
Drugs
temozolomide
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on 2015-000608-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000608-24.